From October 8 to 10, the 11th China Pharmaceutical entrepreneur scientist investor conference and the 70th anniversary of the founding of new China Pharmaceutical Industry Development Achievement Exhibition hosted by China Pharmaceutical Enterprise Management Association was grandly opened. The conference selected a number of important awards in the pharmaceutical industry, and Yiling pharmaceutical won the "Jiaozi enterprise in the pharmaceutical industry in the 70th anniversary of the founding of new China" award, and won the "top 100 pharmaceutical innovation enterprises in China".
2019 is the 70th anniversary of the motherland. In order to fully demonstrate the 70 year glorious history of the Republic from the perspective of the pharmaceutical industry and build a dream of a strong pharmaceutical country, 20 industry associations (schools) including China Pharmaceutical Enterprise Management Association decided to jointly hold a series of celebrations and commemorations of "magnificent 70 years, striving for a new era - great changes in the pharmaceutical industry". After months of collection, arrangement and industry recommendation, Yiling pharmaceutical was finally awarded the "Jiaozi enterprise of pharmaceutical industry in the 70th anniversary of the founding of new China". Yiling pharmaceutical won these two honors, which are closely related to the development strategy of the enterprise in recent years. Under the leadership of Academician Wu Yiling, Yiling pharmaceutical always adheres to the innovation and development strategy driven by market leader and science and technology, and uses modern high and new technology to research and develop traditional Chinese medicine, western medicine and health products. A unique operation mode of "theory clinical scientific research industry teaching" has been established, forming three business sectors of science and technology traditional Chinese medicine, international pharmaceutical and health industry, and its influence in the field of pharmaceutical industry continues to grow.
In the future, Yiling pharmaceutical will also update its concept, transform its organization, reshape its business form, and ensure its implementation. The five business sectors of traditional Chinese medicine, chemical medicine, health industry, medical treatment and capital operation will keep pace with each other, striving to build the largest and most influential health industry carrier in China.